Q1 2019 Holdings
Filed 2019-05-15 | 104 holdings | $50.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2019-06-20) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $9.7M | 1,069,089 | 19.1% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $8.2M | 447,970 | 16.2% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $8.0M | 68,273 | 15.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $7.1M | 30,000 | 14.0% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $6.1M | 192,994 | 12.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.2M | 33,581 | 8.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $2.9M | 198,053 | 5.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $2.0M | 183,151 | 3.9% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $1.0M | 75,600 | 2.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $336.0K | 83,607 | 0.7% |
| Spdr Series Trust(XBI)Put | PUT | 78464A870 | $302.0K | 3,335,000 | 0.6% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $42.0K | 879,900 | 0.1% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $37.0K | 265,000 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $33.8K | 2,488,078 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $33.4K | 247,300 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $31.4K | 377,000 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $31.2K | 480,000 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $28.4K | 1,002,307 | 0.1% |
| Celgene Corp(CELG)Put | PUT | 151020104 | $28.3K | 300,000 | 0.1% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $28.3K | 700,000 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $23.6K | 250,000 | 0.0% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $20.9K | 400,000 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $18.0K | 430,000 | 0.0% |
| Verint SYS Inc(VTY) | COM | 92343X100 | $15.8K | 263,926 | 0.0% |
| Biogen Inc(BIIB)Put | PUT | 09062X103 | $14.2K | 60,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $13.2K | 83,796 | 0.0% |
| Uniqure NV(QURE)Call | CALL | N90064101 | $11.9K | 200,000 | 0.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $11.4K | 308,377 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $11.2K | 100,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $9.9K | 435,678 | 0.0% |
| Novartis A G(NVSN) | SPONSORED ADR | 66987V109 | $9.6K | 100,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $8.7K | 73,405 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $8.3K | 220,500 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $7.8K | 975,000 | 0.0% |
| Allot Communications LTD(ALLT) | SHS | M0854Q105 | $7.7K | 965,931 | 0.0% |
| Palo Alto Networks Inc(PANW) | COM | 697435105 | $7.5K | 30,754 | 0.0% |
| Caesarstone LTD(CSTE) | ORD SHS | M20598104 | $7.5K | 478,114 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $7.2K | 61,397 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $7.1K | 150,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $7.0K | 81,769 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $6.9K | 1,432,643 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $6.8K | 5,108,333 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.3K | 326,660 | 0.0% |
| Camtek LTD(CAMT) | ORD | M20791105 | $6.2K | 700,574 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $6.0K | 181,625 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $6.0K | 303,930 | 0.0% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $5.9K | 5,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $5.9K | 113,000 | 0.0% |
| Mellanox Technologies LTD | SHS | M51363113 | $5.8K | 49,394 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $5.7K | 2,201,697 | 0.0% |